Impaired autophagy: The collateral damage of lysosomal storage disorders

被引:44
|
作者
Myerowitz, Rachel [1 ]
Puertollano, Rosa [2 ]
Raben, Nina [2 ]
机构
[1] St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA
[2] NHLBI, Cell & Dev Biol Ctr, NIH, 50 South Dr Room 3533, Bethesda, MD 20892 USA
来源
EBIOMEDICINE | 2021年 / 63卷
基金
美国国家卫生研究院;
关键词
Lysosome; Autophagy; Gaucher disease; Batten disease; Danon disease; Pompe disease; Cystinosis; ENZYME REPLACEMENT THERAPY; MOUSE MODEL; DISEASE; DEGRADATION; PROTEIN; BIOGENESIS; CYSTINOSIS; MUTATIONS; LAMP-2; TFEB;
D O I
10.1016/j.ebiom.2020.103166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lysosomal storage disorders (LSDs), which number over fifty, are monogenically inherited and caused by mutations in genes encoding proteins that are involved in lysosomal function. Lack of the functional protein results in storage of a distinctive material within the lysosomes, which for years was thought to determine the pathophysiology of the disorder. However, our current view posits that the primary storage material disrupts the normal role of the lysosome in the autophagic pathway resulting in the secondary storage of autophagic debris. It is this "collateral damage" which is common to the LSDs but nonetheless intricately nuanced in each. We have selected five LSDs resulting from defective proteins that govern widely different lysosomal functions including glycogen degradation (Pompe), lysosomal transport (Cystinosis), lysosomal trafficking (Danon), glycolipid degradation (Gaucher) and an unidentified function (Batten) and argue that despite the disparate functions, these proteins, when mutant, all impair the autophagic process uniquely. (C) 2020 The Authors. Published by Elsevier B.V.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Therapy for Lysosomal Storage Disorders
    Beck, Michael
    IUBMB LIFE, 2010, 62 (01) : 33 - 40
  • [32] DIAGNOSIS OF LYSOSOMAL STORAGE DISORDERS
    KERR, C
    MEDICAL JOURNAL OF AUSTRALIA, 1984, 140 (04) : 188 - 189
  • [33] Lysosomal Storage Disorders and Iron
    Bras, Jose Miguel
    METAL RELATED NEURODEGENERATIVE DISEASE, 2013, 110 : 251 - 275
  • [34] Treatment for Lysosomal Storage Disorders
    Sheth, Jayesh
    Nair, Aadhira
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (40) : 5110 - 5118
  • [35] Prevalence of lysosomal storage disorders
    Meikle, PJ
    Hopwood, JJ
    Clague, AE
    Carey, WF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (03): : 249 - 254
  • [36] Sphingolipid lysosomal storage disorders
    Frances M. Platt
    Nature, 2014, 510 : 68 - 75
  • [37] Immunochemistry of lysosomal storage disorders
    Parkinson-Lawrence, Emma
    Fuller, Maria
    Hopwood, John J.
    Meikle, Peter J.
    Brooks, Doug A.
    CLINICAL CHEMISTRY, 2006, 52 (09) : 1660 - 1668
  • [38] Lysosomal Storage Disorders in the Newborn
    Staretz-Chacham, Orna
    Lang, Tess C.
    LaMarca, Mary E.
    Krasnewich, Donna
    Sidransky, Ellen
    PEDIATRICS, 2009, 123 (04) : 1191 - 1207
  • [39] PSEUDODEFICIENCIES IN LYSOSOMAL STORAGE DISORDERS
    ZLOTOGORA, J
    BACH, G
    LANCET, 1985, 2 (8467): : 1296 - 1296
  • [40] Treatments for lysosomal storage disorders
    Lachmann, Robin
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 1465 - 1468